,您好,欢迎光临投融界! [退出]
欢迎来到投融界[登录][免费注册]
投融界 > 企业投资人 > 唐南珊
投资人物
投资人热度3053
唐南珊

唐南珊
上海

沃脉德资本

奥博医疗资本有限公司

投资人

主席/资深董事总经理

投资领域
  • 医疗保健
  • 生物医药
简介

Dr. Nancy Chang, joined OrbiMed in 2007 as a Managing Director, Asia. Dr. Chang was the Co-Founder, CEO and Chairman of Tanox, Inc. She brings over 25 years of excellence in pioneering scientific research and entrepreneurial success to OrbiMed.

Dr. Chang built Tanox from an idea to a substantial publicly-traded company which was acquired by Genentech in August 2007 for $919 Million. Tanox’s initial public offering in 2000 was the second largest IPO ever for a biotechnology company at that time. During her career, Dr. Chang has received numerous awards for her leadership, including the Most Respected Woman in Biotechnology (MedAd News, 2005), Global Business Achievement Hall of Fame Governor’s Award (2005), Texas Science Hall of Fame (2001), and Houston Entrepreneur of the Year (2000).

Dr. Chang serves on the Boards of Directors of the Federal Reserve Bank in Houston, Charles River Laboratories, and she is also a member of the Board of Visitors at M. D. Anderson Cancer Center. Before launching Tanox, Dr. Chang served as Director of Research at Centocor, Inc. She received her Ph.D. in Biological Chemistry from Harvard University.

投资项目
暂未收入该公司投资项目信息
联系方式
评论
发布留言
相关新闻
相关人物
项目推荐
认领用户

暂无认领用户

我要认领
投融界小程序
今日已有0人投递合作需求

金额

输入手机号码

立即申请

扫一扫,加关注
×